Clinical trial Recruiting at 1 site Interventional Ages 1 Year to 5

Screening for neurodevelopmental disorders in children with congenital heart disease

Official title: Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease

Run by University Hospital, Montpellier · NCT06431269 · Data updated 2026-11-12

This study tests if regular check-ups can help find neurodevelopmental disorders in young children with congenital heart disease.

More Neurodevelopmental Disorders trials

Quick facts

Study typeInterventional
Ages1 Year to 5 Years
SexAll
Enrollment270 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations3 sites (Montpellier and 2 other locations)
StatusRecruiting
StartedMay 31, 2024
Main results expectedJune 2028
Study endsJune 2028
Registry record updatedSeptember 25, 2025
Trial IDNCT06431269 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1 to 5 years with stable congenital heart disease and no prior diagnosis of neurodevelopmental disorders.

Probably not a fit

Patients with genetic or poly-malformative syndromes requiring specialized neurodevelopmental care may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the feasibility and efficiency of screening for neurodevelopmental disorders (NDD) in children aged 1 to 5 years who have congenital heart disease (CHD). An Advanced Practice Nurse (APN) will conduct systematic screenings during routine cardiac follow-ups. If NDD is suspected, children will be referred to a neuropsychologist for further evaluation and management. The study addresses the gap in medical resources for early NDD detection in this vulnerable population.

Why it matters

Potential benefit: If successful, this approach could lead to earlier diagnosis and management of neurodevelopmental disorders in children with congenital heart disease, improving their long-term quality of life.

How similar studies have gone: While similar approaches have been explored, this specific method of screening by an Advanced Practice Nurse in this population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Congenital heart disease with stable status defined by last operation \>3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
* Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
* Patient aged 1 to 5 years.
* No previous medical diagnosis of NDD
* Parental or legal guardian's consent.
* Social security affiliation (for France only)

Exclusion Criteria:

* Patients with a genetic or poly-malformative syndrome with known neurological impairment.
* Neurodevelopmental disorder already known/treated
* Neurodevelopmental status evaluation within the last 6 months.

Where it's running

  • University Hospitial of Montpellier
    Montpellier, France
    Recruiting
  • Institut Marin Saint-Pierre
    Palavas-les-Flots, France
    Not yet recruiting
  • CHU Bordeaux Haut-Lévêque
    Pessac, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.